Form 4 holding
Chief Commercial Officer
Xenon Pharmaceuticals Inc.
- Security class
- Share Option (Right to Buy)
- Shares / value
- 40,000
- Estimated value
- Report date
- 09 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount